Skip to main content
OpenTrials
Completed

NCT Number: NCT02264782

PreView: The Preventive Video Education in Waiting Rooms Program

This clinical trial studies how well PreView, preventive video education, works in increasing rates of breast, cervical and colorectal cancer screening, improving participants' stage of change with respect to age appropriate cancer screening and increasing patient-provider discussions about prostate cancer screening.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Health Status Unknown

Age range

50 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

John Muir Medical Center-Concord Campus, Concord, California, United States

Loading trial locations.

About this study

PRIMARY OBJECTIVES:

I. To determine the extent to which PreView increases the likelihood that primary care patient participants will receive mammograms, pap tests, colon cancer tests or prostate specific antigen (PSA) testing discussions with primary care physicians compared with participants who receive usual care.

II. To determine the extent that PreView increases participants' readiness to be screened for breast cancer, cervical cancer or colorectal cancer (CRC) compared with usual care.

III. To determine the extent that PreView increases the likelihood that PSA testing will be discussed in primary care physician visits compared with usual care.

OUTLINE: Patients are randomized into 1 of 2 groups.

GROUP I: Patients complete PreView, the Video Doctor plus Provider Alert, over 45 minutes on an iPad in the waiting room before a doctor visit.

GROUP II: Patients watch a video about healthy lifestyles including information about exercise and healthy eating over 45 minutes on an iPad in the waiting room before a doctor visit.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Without a history of cancer

Exclusion criteria

  • With a history of cancer (for whom subsequent procedures would be surveillance and not screening)
  • Individuals who do not speak English or Spanish (except for the testimonials)

Treatment and study plan

Computer-Assisted Intervention

Other

Complete PreView

Questionnaire Administration

Other

Ancillary studies

Primary outcomes

  1. Changing participants' readiness to be screened for breast, cervical and colorectal cancer

    Time frame: Up to 3 hours from pre-visit to post-visit interview.

    To determine the extent to which PreView increases the likelihood that primary care patient participants will receive mammograms, Pap tests, colon cancer tests or PSA testing discussions with primary care physicians compared with participants who receive usual care

  2. Increasing physician-patient discussions about PSA screening measured by chart review

    Time frame: Baseline up to 14 months

    To determine the extent that PreView increases participants' readiness to be screened for breast cancer, cervical cancer or CRC compared with usual care.

  3. Increasing rates of breast, cervical and colorectal cancer screening

    Time frame: From Baseline up to 14 months

    To determine the extent that PreView increases the likelihood that PSA testing will be discussed in primary care physician visits compared with usual care.

Sponsors and collaborators

Lead sponsor

University of California, San Francisco

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Important dates

Study start
2013
Primary completion
2019
Study completion
2019
First posted
Oct 15, 2014
Registry last updated
Jul 22, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.